Congenital myasthenic syndromes by Epsilon subunit mutations: Phenotypic profiles of 17 Algerian families

Rev Neurol (Paris). 2025 Jan-Feb;181(1-2):79-84. doi: 10.1016/j.neurol.2024.09.007. Epub 2024 Oct 7.

Abstract

Background: Congenital myasthenic syndromes (CMS) are a heterogeneous group of rare genetic disorders. The acetyl choline receptor contains five subunits, with a predominance of mutations affecting the epsilon subunit gene called cholinergic receptor nicotinic epsilon (CHRNE) gene.

Objective: To study the clinical phenotype of 17 families with CHRNE gene mutations.

Methods: We report a series of 17 families with 22 affected patients carrying different mutations encoding CHRNE proteins.

Results: We studied their clinical and biological phenotypes, as well as their evolutionary profile and their response to the different therapies proposed. A phenotypic comparison was made between the families carrying the founding Maghrebian mutation and the other mutations found in this series.

Conclusion: The CHRNE gene mutations are the most frequent ones in CMS. The phenotypes reported in this study are heterogeneous, and can depend on the causative mutation.

Keywords: CHRNE; Congenital; Myasthenia; Phenotype; Post-synaptic.

MeSH terms

  • Adolescent
  • Adult
  • Algeria / epidemiology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Mutation*
  • Myasthenic Syndromes, Congenital* / genetics
  • Pedigree
  • Phenotype*
  • Receptors, Nicotinic* / genetics
  • Young Adult

Substances

  • Receptors, Nicotinic
  • CHRNE protein, human